Cybrexa appoints Jaya Gautam as SVP of technical operations

US clinical-stage oncology biotech Cybrexa Therapeutics has appointed Jaya Gautam as senior vice president, technical operations.

Dr Gautam joins several other recent company-wide hires, all of whom have been tasked with advancing and scaling CBX-12 into Phase II clinical trials and providing strategic support for the additional pipeline assets, like CBX-15, as the company prepares for investigational new drug (IND) submission.

“We are pleased to have Jaya join us at a pivotal point in the clinical development of our lead therapeutic, CBX-12, as we prepare to enter Phase II clinical trials,” said Per Hellsund, president and chief executive of Cybrexa. “Jaya offers extensive experience in operations as well as peptide and small molecule manufacturing that strongly align with the needs of our evolving pipeline and our growing clinical and commercial objectives,” he noted.